Elon Musk's Neuralink Joins Bionic Eye Study with UC Santa Barbara
PorAinvest
viernes, 25 de julio de 2025, 11:17 pm ET1 min de lectura
Neuralink, a brain implant company founded by Elon Musk, is collaborating with researchers in California and Spain on a clinical trial to study visual prosthetics. The goal of the study is to develop a "Smart Bionic Eye" using AI that could help blind people identify faces, navigate outdoors, and read. Neuralink's participation in the trial was disclosed on ClinicalTrials.gov and the study is currently enrolling patients by invitation.
Title: Neuralink Joins Clinical Trial to Develop Smart Bionic EyeNeuralink, Elon Musk's brain implant company, has joined a clinical trial to study visual prosthetics, with the aim of developing a "Smart Bionic Eye" using artificial intelligence (AI). The trial, sponsored by the University of California at Santa Barbara (UCSB), seeks to address fundamental questions that will allow the development of a device capable of helping blind people identify faces, navigate outdoors, and read.
Neuralink's participation in the trial was disclosed on ClinicalTrials.gov, a government website listing medical studies. The study, which is currently enrolling patients by invitation, aims to integrate Neuralink's brain-computer interface expertise with specialized vision restoration research. The specific role Neuralink will play in the trial is not yet clearly defined, but the study description indicates that Neuralink patients will be included "once available."
Neuralink is developing a brain chip called Blindsight, which aims to restore vision to blind people and grant superhuman vision. The device has been tested in monkeys but has not yet been tested on human patients. Musk's company aims to roll out Blindsight by 2030 and expects to generate $1 billion in annual revenue from at least three different types of brain implants by 2031.
The collaboration between Neuralink and UCSB, along with researchers from California and Spain, represents a significant advancement in neural interface technology applications. The trial is expected to provide valuable insights into the potential of AI-powered visual prosthetics and the role of brain implants in restoring vision.
References
[1] https://www.bloomberg.com/news/articles/2025-07-25/elon-musk-s-neuralink-joins-study-working-toward-a-bionic-eye
[2] https://www.investing.com/news/company-news/neuralink-joins-university-of-california-study-to-develop-aipowered-bionic-eye-93CH-4153841
[3] https://www.business-standard.com/world-news/musk-s-neuralink-joins-study-working-on-bionic-eye-with-uc-santa-barbara-125072600117_1.html

Divulgación editorial y transparencia de la IA: Ainvest News utiliza tecnología avanzada de Modelos de Lenguaje Largo (LLM) para sintetizar y analizar datos de mercado en tiempo real. Para garantizar los más altos estándares de integridad, cada artículo se somete a un riguroso proceso de verificación con participación humana.
Mientras la IA asiste en el procesamiento de datos y la redacción inicial, un miembro editorial profesional de Ainvest revisa, verifica y aprueba de forma independiente todo el contenido para garantizar su precisión y cumplimiento con los estándares editoriales de Ainvest Fintech Inc. Esta supervisión humana está diseñada para mitigar las alucinaciones de la IA y garantizar el contexto financiero.
Advertencia sobre inversiones: Este contenido se proporciona únicamente con fines informativos y no constituye asesoramiento profesional de inversión, legal o financiero. Los mercados conllevan riesgos inherentes. Se recomienda a los usuarios que realicen una investigación independiente o consulten a un asesor financiero certificado antes de tomar cualquier decisión. Ainvest Fintech Inc. se exime de toda responsabilidad por las acciones tomadas con base en esta información. ¿Encontró un error? Reportar un problema



Comentarios
Aún no hay comentarios